Hui-Hui Yang Selected Research

dual inhibitor PTUPB

6/2020	A COX-2/sEH dual inhibitor PTUPB ameliorates cecal ligation and puncture-induced sepsis in mice via anti-inflammation and anti-oxidative stress.
1/2020	A COX-2/sEH dual inhibitor PTUPB alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting NLRP3 inflammasome activation.
1/2020	COX-2/sEH dual inhibitor PTUPB alleviates bleomycin-induced pulmonary fibrosis in mice via inhibiting senescence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hui-Hui Yang Research Topics

Disease

13	Acute Lung Injury 01/2023 - 01/2018
11	Inflammation (Inflammations) 12/2023 - 01/2018
7	Neoplasms (Cancer) 01/2023 - 10/2016
6	Pulmonary Fibrosis (Fibrosing Alveolitis) 06/2023 - 01/2020
4	Lung Injury 12/2023 - 01/2020
3	Fibrosis (Cirrhosis) 12/2021 - 01/2020
2	Premature Aging 12/2023 - 01/2023
2	Sepsis (Septicemia) 03/2023 - 06/2020
2	Non-alcoholic Fatty Liver Disease 07/2022 - 01/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2023
1	Mental Disorders (Mental Disorder) 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023
1	Immune System Diseases (Immune Disorders) 01/2023
1	Metabolic Diseases (Metabolic Disease) 01/2023
1	Myocardial Infarction 01/2023
1	COVID-19 01/2022
1	Optic Atrophy 01/2022
1	Sleep Wake Disorders 01/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Infections 01/2022
1	Rupture 01/2021
1	Necrosis 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Fatty Liver 01/2020
1	Obesity 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Uveitis 01/2020
1	Hepatitis 01/2020
1	Reperfusion Injury 01/2020
1	Weight Loss (Weight Reduction) 01/2020
1	Arthritis (Polyarthritis) 01/2020
1	Idiopathic Pulmonary Fibrosis 09/2019
1	Septic Shock (Toxic Shock Syndrome) 01/2019
1	Fatigue 06/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2016

Drug/Important Bio-Agent (IBA)

11	LipopolysaccharidesIBA 12/2023 - 01/2018
8	InflammasomesIBA 03/2023 - 01/2020
6	Arachidonic Acid (Vitamin F)IBA 07/2022 - 01/2020
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2016
5	Bleomycin (Blenoxane)FDA LinkGeneric 12/2022 - 01/2020
3	Epoxide HydrolasesIBA 12/2023 - 12/2020
3	Citric Acid (Citrate)FDA LinkGeneric 06/2023 - 12/2021
3	CollagenIBA 07/2022 - 09/2015
3	LipidsIBA 07/2022 - 01/2020
3	AcidsIBA 01/2022 - 12/2020
3	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 12/2021 - 01/2018
3	dual inhibitor PTUPBIBA 06/2020 - 01/2020
2	Galactose (Galactopyranose)FDA LinkGeneric 12/2023 - 01/2023
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2023 - 07/2022
2	LipocalinsIBA 01/2023 - 01/2023
2	Therapeutic UsesIBA 01/2023 - 01/2018
2	Triggering Receptor Expressed on Myeloid Cells-1IBA 01/2023 - 12/2020
2	Triglycerides (Triacylglycerol)IBA 07/2022 - 01/2020
1	AntioxidantsIBA 12/2023
1	BenzenesulfonamidesIBA 12/2023
1	SmokeIBA 12/2023
1	Calcitonin Gene-Related PeptideIBA 03/2023
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 01/2023
1	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 01/2023
1	Lipocalin-2IBA 01/2023
1	ElementsIBA 01/2023
1	EndotoxinsIBA 01/2023
1	Urea (Carbamide)FDA LinkGeneric 01/2023
1	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 01/2023
1	Apolipoproteins D (Apo D)IBA 01/2023
1	indium-bleomycinIBA 12/2022
1	Sirtuin 1IBA 07/2022
1	Glucose (Dextrose)FDA LinkGeneric 07/2022
1	aloperineIBA 06/2022
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2022
1	NeuropeptidesIBA 12/2021
1	Pyrin Domain-Containing 3 Protein NLR FamilyIBA 12/2021
1	Messenger RNA (mRNA)IBA 05/2021
1	Ligases (Synthetase)IBA 05/2021
1	IronIBA 01/2021
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021
1	ResveratrolIBA 07/2020
1	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 01/2020
1	CholesterolIBA 01/2020
1	Ficusin (Psoralen)IBA 01/2020
1	Galectin 1 (LGALS1)IBA 01/2020
1	angiotensin I (1-7)IBA 09/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	Shen-FuIBA 01/2019
1	XanthenesIBA 10/2018
1	Interleukin-17 (Interleukin 17)IBA 01/2018
1	SolutionsIBA 06/2017
1	AlloysIBA 06/2017
1	Epoxy Resins FDA Link 06/2017
1	Monoamine Oxidase (MAO)IBA 06/2017
1	dibenzoxanthenesIBA 01/2017

Therapy/Procedure

2	Ligation 01/2023 - 06/2020
2	Punctures 01/2023 - 06/2020
2	Therapeutics 10/2021 - 01/2020
1	Exercise Therapy (Therapy, Exercise) 01/2022
1	Catheters 01/2019
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2019
1	Resuscitation 01/2019